The issue of refractory disease in follicular and other lymphoma subtypes

Revista Brasileira de Hematologia e Hemoterapia

Marco Ruella²  Angela Gueli²  Alessandra Risso¹  Irene Ricca¹  Daniela Gottardi¹  Alberto De Crescenzo¹  Roberto Passera¹  Marco Ladeto¹  Corrado Tarella¹ 

[1] ,Università di Torino Facoltà di Medicina e Chirurgia Molecular Biotechnology CenterTorino,Italy

关键词: Hodgkin's lymphoma;    non-Hodgkin's lymphoma;    chemotherapy;    autologous stem cell transplantation;    refractory disease;    Linfoma de Hodgkin;    linfomas não Hodgkin;    quimioterapia;    transplante autólogo de células-tronco;    doença refratária;   

DOI  :  10.1590/S1516-84842009000800005

来源: SciELO

【 摘 要 】

The outcome of lymphoma has definitely improved over the last few decades which is mainly due to the introduction and development of novel and effective therapeutic approaches. Nevertheless, a small though notable group of patients may display a poor response to treatments, with a true refractoriness or a transient response followed by early relapse. The present review addresses the issue of refractory disease among patients with lymphoma, focusing on the overall incidence and the main clinical aspects associated with refractoriness.

【 授权许可】

CC BY-NC-ND   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License